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FibroblastRett syndrome (RTT) is a neurodevelopmental disorder caused by MECP2 mutations. Previous stud-
ies performed on Mecp2-deﬁcient brain showed striking changes in neuronal maturation. We
recently showed that MeCP2 deﬁciency affects microtubule (MT) dynamics in RTT astrocytes. Here,
we analyze MT stability in primary ﬁbroblast cultures from patients with RTT syndrome and identify
a signiﬁcant decrease in stability compared to controls. Furthermore, we found that MT stability was
reduced both in cells expressing the mutant or the wild-type allele in RTT ﬁbroblasts, suggesting
that mutated cells could damage wild-type ones through a non-cell-autonomous pathway. These
results suggest that MeCP2 has a stabilizing role on MT dynamics and that its deﬁciency could lead
to impaired MT stability that may explain in part the dendritic abnormalities observed in RTT brains.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The postnatal neurodevelopmental disorder Rett syndrome
(RTT, MIM 312750) is the only one of the ﬁve pervasive develop-
mental disorders (including autism) with a known genetic cause
(Diagnostic and Statistical Manual of Mental Disorders, 4th Edi-
tion). RTT is caused by mutations in the gene encoding methyl-
CpG binding protein 2 (MeCP2) [1].MECP2mutations are identiﬁed
in 90% and 50% of cases of typical and atypical RTT, respectively
[2]. RTT is characterized by apparently normal development for the
ﬁrst few months followed by loss of neurodevelopmental mile-
stones, similar to what is observed in regressive forms of autism.
Clinical features include developmental stagnation and regression,
loss of purposeful hand movements and speech, severe autistic fea-
tures, truncal ataxia, stereotypic hand movements, deceleration of
brain growth, autonomic dysfunction and seizures [3]. In addition,
whereas MECP2 mutations seem to be rare in Autism Spectrum
Disorders (ASD), MECP2 mRNA levels were found to be reduced
in the absolute majority of ASD cortex [4–7].
Increasing evidence supports the idea that RTT is associated
with impairment of dendritic arborization. Several studies de-scribed neuronal abnormalities in RTT human brains, and in male
Mecp2-mutant mice [8–13]. All these studies suggested that
MECP2 mutation could be involved in cellular mechanisms regu-
lating short term dynamics of dendritic spines early in develop-
ment within the frame of maximum neural plasticity. However,
the underlying cause of the dendritic arborization impairment is
largely unknown. Because we and others identiﬁed dysregulated
expression of proteins involved in regulation of MT dynamics
and functions (STMN2 and the ubiquitin-editing enzyme UCHL1,
Dynamin I, Dynein I) [14–16], we recently analyzed MT stability
and dynamics in mouse Mecp2-deﬁcient cells and showed an
alteration of MT dynamics in RTT astrocytes [16]. Recent studies
on astrocytes demonstrated that Mecp2-deﬁcient astrocytes det-
rimentally inﬂuence the neuronal dendrite formation in a non-
cell-autonomous way [17,18]. MT dynamics alterations may thus
contribute to the neuronal dysfunction and to the synaptic plas-
ticity defect, and may explain reduced dendritic branching ob-
served in Mecp2-deﬁcient mice and patients with RTT
syndrome [8,9,12,13].
Here we studied microtubule dynamics in human MeCP2 mu-
tant cells, and we report that MeCP2 deﬁciency affects MT stability
and dynamics in ﬁbroblasts from patients with RTT syndrome. Fur-
thermore, we found that MT stability was affected in cells express-
ing the mutant allele as well as in cells expressing the wild-type
allele in human ﬁbroblasts from RTT patient, suggesting that mu-
tated cells could damage wild-type cells through a non-cell-auton-
omous pathway.
Fig. 1. Effect of cold-induced stress on polymerized MT in ﬁbroblasts from RTT patient (p.Arg270X) and from normal control (WT). Immunoﬂuorescent staining of a-tubulin
for WT and RTT ﬁbroblasts after 0, 5, 8, 11, and 30 min at +4 C. MT from RTT ﬁbroblasts depolymerize faster than MT fromWT ﬁbroblasts. After 30 min at +4 C, MT from both
cell cultures appear totally depolymerized.
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2.1. Cell culture and single cell cloning for ﬁbroblasts
A skin biopsy was performed on ﬁve girls suffering from typical
RTT after obtained consent of the parents. Three of them exhibited
a non-sense mutation (p.Arg168X; p.Arg255X; p.Arg270X)
whereas two harboured a missense mutation (p.Ala2Val;
p.Arg306Cys) in MECP2 gene. For an accurate comparison, our pa-
tients had a convergent, classical RTT phenotype and a similar age
(8–9 years old). Normal controls were obtained from unaffected fe-
males aged 18–20 years. In all studied cases, no X-chromosome
inactivation bias was detected in cultured ﬁbroblasts in vitro from
1 to 4 passages. Additional skin biopsies from two patients suffer-
ing from atypical RTT and mutated in the CDKL5 gene (p.Arg79X;
and 300 Kb deletion including the CDKL5 gene) were also studied.
Primary ﬁbroblast cultures and clonal cultures were performed as
previously described [19,20]. To prevent from epigenetic differ-ences, primary cultures of untransformed ﬁbroblasts with a low
number of cell divisions were chosen for our study.
2.2. Microtubule (MT)-depolymerizing and repolymerizing treatments
Human ﬁbroblasts were cultured in Dulbecco’s modiﬁed Eagle’s
medium DMEM and supplemented with 10% heat-inactivated fetal
bovine serum and 50 units/ml penicillin and streptomycin. All cul-
tures were routinely grown at 37 C under a 5% CO2 humidiﬁed
atmosphere. Concerning MT-depolymerizing treatment, cells on
sterile glass coverslips were incubated in the refrigerator (4 C)
for various time intervals (0, 5, 8, 11, and 30 min) before washing
them twice in cold PBS and ﬁxing them in ice-cold methanol for
7 min at 20 C. For reversibility study, in order to induce MT-
repolymerization, after a 30-minutes cold treatment, cells were
incubated at 37 C for various time intervals (0, 4, and 8 min) be-
fore washing them twice in PBS and ﬁxing them in ice-cold meth-
anol for 7 min at 20 C.
Fig. 2. Effect of cold-induced stress on polymerized MT (PMT) in ﬁbroblasts from
patients with RTT syndrome and from normal controls after 8 min at +4 C. This
graph represents the relative cell area occupied by the microtubule network (ratio
between the area occupied by PMT to the whole cell area) for WT (WT1, WT2 and
WT3) and RTT ﬁbroblast cultures bearing different types of MECP2 mutations such
as non-sense mutations (p.Arg168X; p.Arg255X; p.Arg270X) and missense muta-
tions (p.Arg306Cys). After 8 min at +4 C, MeCP2-deﬁcient ﬁbroblasts MT are almost
totally depolymerized whereas normal controls still show several PMT.
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Quantiﬁcation of cellular tubulin in microtubules and tubulin
pools was performed using the microtubules/tubulin in vivo assay
kit (Cytoskeleton, Denver, Colorado, USA) according to the manu-
facturer instructions. In brief, cells were incubated in lysis buffer
in the presence of 100 lM GTP, and centrifugated at 100000g
for 30 min in an TLA45 rotor in a Beckman ultracentrifuge (Beck-
man instruments, Palo Alto, CA). Amount of free tubulin and micro-
tubules in supernatant and pellets was determined by Western
blot using the tubulin antibody provided at 1:1000 dilution.
2.4. Antibodies
The primary antibodies used for semi-quantitative or qualita-
tive studies were: antibody against the C-terminal domain of
MeCP2 (amino acids 465–478) (M9317, Sigma, Lyon, France, 1/
1000), anti-a tubulin (Sigma T9026, 1/1000), anti-acetylated tubu-
lin (Sigma M6793, 1/2000), anti-tyrosinated tubulin (Sigma T9028,
1/1000). For normalization, anti-GAPDH (Santa Cruz Biotechnol-
ogy, Heidelberg, Germany, 1/2000) have been used.
2.5. Western blotting
Brieﬂy, proteins were extracted from the ﬁbroblasts cultures, by
Laemmli sample buffer two times (BioRad, Richmond, CA, USA).
The protein samples were separated by a 10% sodium dodecyl sul-
fate–polyacrylamide gel electrophoresis and then transferred to
Hybond-C nitrocellulose membrane (GE Healthcare). After block-
ing non-speciﬁc sites by a TBS–Tween 20 0.05%/fat milk 5% solu-
tion, 1 h at room temperature, the membrane was incubated
overnight at 4 C with primary antibody, washed and incubatedwith a horseradish peroxidase (HRP)-conjugated anti-mouse or
anti-goat IgG (dilution 1:5000) and developed with the enhanced
chemiluminescence method (ECL; GE Healthcare).
2.6. Immunostaining
Cells were washed twice with PBS and ﬁxed with methanol at
20 C during 7 min, incubated with appropriated antibodies and
then mounted with Vectashield mounting medium with DAPI
(Vector Laboratories) and analyzed with a Leica DMRA2 ﬂuores-
cence microscope. Quantitative analysis of microtubules was car-
ried out with a Leica DMRA2 ﬂuorescence microscope (Leica,
Rueil-Malmaison, France) and included measurement of their ﬂuo-
rescence using the MetaMorph soltware and analyzis of digital
images collected with a digital CCD camera. For the depolymeriza-
tion quantitative analyzis, extended focus images of a single well-
spread cell per view with minimal thickness were used. Microtu-
bule subpopulations in the area of interest were computed by
the original image segmentation with threshold set of 200% of
background level and by calculating the percentage of above-the-
threshold pixels. The relative area occupied by the microtubule
network in cell compartment was calculated. The ratio between
the area occupied by MT to the whole cell area was determined.
In each experiment and for each condition, at least 30 cells were
quantitatively analyzed. Repolymerization was quantiﬁed as the
percentage of cells with centrosomal MT asters after 4 min incuba-
tion at 37 C. Normal ﬁbroblasts from control individuals were in-
cluded in each experiment. All individual experiments were
performed in triplicate.
2.7. Drug
For microtubule stabilization, ﬁbroblasts were incubated for
30 min either in the absence of drug or with 250 nM paclitaxel
(Taxol, Sigma T1912) and then submitted to cold-induced depoly-
merization during 11 min at 4 C.
3. Results
3.1. MeCP2 deﬁciency affects the rate of MT depolymerization during
cold-induced catastrophe
We ﬁrst investigated whether MT stability is affected by MeCP2
deﬁciency. To this end, we performed a cold-induced MT depoly-
merization in primary cultures of human ﬁbroblasts obtained from
patients with RTT syndrome and analyzed by immunoﬂuorescent
staining of a-tubulin the cytoskeleton morphology at various times
of cold treatment. We clearly observed that MeCP2 deﬁciency af-
fects the rate of MT depolymerization and that MeCP2-deﬁcient
ﬁbroblasts displayed a more pronounced response to cold-induced
stress (Fig. 1). After 8 min at +4 C, MT from RTT ﬁbroblasts are al-
most totally depolymerized whereas normal controls still show
several polymerized MT (Fig. 1). The same results were obtained
with human RTT ﬁbroblasts bearing different types of MECP2
mutations such as non-sense mutations (p.Arg168X; p.Arg255X;
p.Arg270X) and missense mutations (p.Arg306Cys) (Fig. 2).
Because MECP2 is an X-linked gene that undergoes X-chromo-
some inactivation in females, each cell expresses MECP2 exclu-
sively from one of the two X chromosomes (the active X), while
the copy on the inactive X chromosome is silenced. In order to sep-
arate cells that express the wild type from those that express the
mutant MECP2 allele, we performed single-cell cloning of ﬁbro-
blasts isolated from skin biopsy from a RTT patient expressing
exclusively the p.Arg270X mutant allele. We again observed that
MT from MeCP2-deﬁcient ﬁbroblasts bearing the p.Arg270X muta-
Fig. 3. Effect of cold-induced stress on polymerized MT (PMT) in ﬁbroblasts clonal primary cultures from p.Arg270X mutation patient. (A) Immunoﬂuorescent staining of a-
tubulin for WT and mutant clonal culture (p.Arg270X clonal culture) after 8 min at +4 C. (B) Graph representing the relative cell area occupied by the microtubule network
for WT clonal culture and p.Arg270X clonal culture. After 8 min at +4 C, the clonal culture expressing exclusively the WT allele (WT clonal culture) still shows several PMT
whereas the mutant clonal culture (p.Arg270X clonal culture) already shows totally depolymerized MT.
Fig. 4. Effect of cold-induced stress on polymerized MT (PMT) in ﬁbroblasts from
patients with RTT syndrome (lanes 3–5, 3: p.Ala2Val; 4: p.Arg294X; 5: p.Arg168X)
and from normal controls (lanes 1 and 2) after 15 min at +4 C. Quantiﬁcation of
polymerized tubulin was performed by Western blot after centrifugation at
100000g for 30 min. The graph represents the polymerized tubulin ratio before
and after cold treatment.
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as compared to wild-type ﬁbroblasts from the same individual
(Fig. 3).
To conﬁrm our data by an other approach, we quantiﬁed micro-
tubules and tubulins pools by Western blot after ultracentrifuga-
tion. After 15 min at +4 C, polymerized tubulins tend to be
reduced in RTT ﬁbroblasts compared to normal controls (Fig. 4).
All these data suggest that MT from RTT cells are more sensitive
to the depolymerizing effect of cold temperature than those of WT
cells.
3.2. MeCP2 deﬁciency affects MT repolymerization after cold-induced
catastrophe
Next we investigated a temperature-induced MT repolymeriza-
tion. After complete depolymerization at 4 C for 30 min, cells were
shifted back to 37 C for various times (0, 4, and 8 min). The rate of
MT regrowth from the centrosome was noticeably lower in
MeCP2-deﬁcient ﬁbroblasts. After 4 min at 37 C, centrosomal MT
asters appeared in nearly 100% of wild-type cells, but only in
approximately 20% of MeCP2-deﬁcient cells (Figs. 5 and 6). Taken
together, all these results are consistent with reduced MT stability
in RTT cells harboring a MECP2 mutation.
3.3. MeCP2 has a cell- and a non-cell autonomous effect on MT
stability
Using a speciﬁc MeCP2-antibody directed against the C-termi-
nal domain of the MeCP2 protein, we distinguished RTT ﬁbroblastsexpressing the wild-type allele from RTT ﬁbroblasts expressing the
mutated allele (non-sense mutation). Although it appeared to be
more pronounced in MeCP2-deﬁcient cells, MT stability was also
Fig. 5. Effect of MeCP2 deﬁciency on tubulin repolymerization after cold-induced catastrophe. Immunoﬂuorescent staining of a-tubulin for WT and RTT ﬁbroblasts
(p.Arg168X): cells are submitted to a MT repolymerization step following total depolymerization (0, 4, and 8 min at +37 C after 30 min at +4 C).
C. Delépine et al. / FEBS Letters 587 (2013) 245–253 249reduced in cells expressing the wild-type allele in human ﬁbro-
blasts from RTT patient, suggesting that mutated cells could dam-
age wild-type cells through a non-cell-autonomous pathway
(Fig. 6). The same observations were obtained in MT depolymeriza-
tion studies in human RTT ﬁbroblasts.
3.4. CDKL5 deﬁciency does not affect MT stability
Considering the similar phenotypes caused by mutations in
MECP2 and CDKL5, an X-linked gene involved in atypical form of
RTT, it has been suggested that the two genes could play a role
in a common pathogenic process [21–24]. It has been shown that
CDKL5 is a protein whose expression in the nervous system over-
laps with that of MeCP2 during neural maturation and synaptogen-
esis. Down-regulating CDKL5 by RNA interference (RNAi) in
cultured cortical neurons inhibited neurite outgrowth and den-
dritic arborization development through a cytoplasmic mecha-
nism, whereas over-expressing CDKL5 had opposite effects [23].To ﬁnd if the cellular consequences of the deﬁciency of these two
proteins are similar, we performed the same cellular approaches
in ﬁbroblasts from two atypical patients with RTT syndrome bear-
ing CDKL5 mutations (p.Arg59X mutation; deletion of exon 16 of
the CDKL5 gene). We did not observe any signiﬁcant difference
either in terms of MT depolymerization when cells were incubated
at 4 C, nor in terms of repolymerization after cells were shifted
back to 37 C (Fig. 7). These results suggest that MeCP2 and CDKL5
may probably not share the same molecular and cellular pathway
and that MT stability impairment described above is likely to be
speciﬁc to a MeCP2 deﬁciency.
3.5. MeCP2 deﬁciency affects acetylated but not tyrosinated MT
dynamics
In 2004, Matarazzo and Ronnett found evidence of temporal
and regional proteomic pattern differences between wild-type
and Mecp2-deﬁcient mice, and conclude that not only transcrip-
Fig. 6. Quantiﬁcation of MT repolymerization as the percentage of cells with
centrosomal MT asters after 4 min of incubation at 37 C in WT and RTT
(p.Arg270X) ﬁbroblasts. Cells from RTT culture display signiﬁcantly less repoly-
merized MT as compared to control (WT1 and WT2). Within the RTT ﬁbroblast
culture, MeCP2 deﬁcient cells (MeCP2  cells) show two times less repolymerized
MT than those expressing the WT allele (MeCP2 + cells), suggesting that MeCP2 has
a cell- and a non-cell-autonomous effect on MT dynamics.
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protein expression, but posttranslational protein modiﬁcations as
well [25]. We speculated that MeCP2 may be involved in post-
translational modiﬁcation of tubulin, and in MT stability modiﬁca-
tion, although the precise relationship between these tubulin mod-
iﬁcations and MT stability has not been elucidated. Usually,
acetylated tubulins are known to exist in stable, long-lived MT
whereas tyrosinated tubulins are present in labile and neoformed
MT [26]. To investigate whether the faster MT depolymerizationFig. 7. Effect of cold-induced stress on polymerized MT (PMT) in RTT ﬁbroblasts pr
depolymerization at +4 C, the culture from the CDKL5 mutation patient shows no differ
CDKL5-mutated ﬁbroblasts do not exhibit increased sensitivity to cold-induced stress.in MeCP2-deﬁcient cells is related to a change of acetylated and/
or tyrosinated tubulin level, we carried out Western blot analysis,
which allow estimating the total pool of tubulins (i.e. solu-
ble + polymerized) at two points of our depolymerisation kinetics:
0 and 8 min at +4 C. During depolymerization, a marked decrease
of acetylated tubulin without any changes in total a-tubulin and
tyrosinated tubulin was observed (Fig. 8A). Interestingly, although
we observed a heterogeneity likely due to X chromosome inactiva-
tion status, the quantiﬁcation of this deacetylation in WT and RTT
cultures during depolymerization show that tubulins from RTT
ﬁbroblasts are faster deacetylated than tubulins from the WT cul-
ture (Fig. 8B). These data are consistent with the reduced MT sta-
bility observed above.
3.6. Taxol corrects the defect of MT stability in MeCP2-deﬁcient cells
To investigate the ability of Paclitaxel (taxol), a common MT
stabilizer, to correct the impaired cellular phenotype observed dur-
ing cold-induced stress on RTT ﬁbroblasts, cells were incubated in
the absence of drug or with 250 nM taxol for 30 min, and then sub-
jected to depolymerization 11 min at 4 C. As expected, after
11 min at 4 C in the absence of taxol, MT from RTT ﬁbroblasts
are signiﬁcantly more depolymerized than the WT control, thus
conﬁrming again the MT stability impairment in the MeCP2-deﬁ-
cient cells. After a 30 min treatment with 250 nM taxol, RTT ﬁbro-
blasts no longer show difference in terms of rate of
depolymerization, i.e. in terms of cold-stress sensitivity. Thus, it
can be postulated that taxol is able to correct the faster MT depo-
lymerization observed on RTT ﬁbroblasts, at least in our experi-
mental conditions (Fig. 9).
4. Discussion
Increasing evidence supports the idea that Rett syndrome is
associated with impairment of dendritic arborization. Several stud-
ies described neuronal abnormalities in RTT human brains and in
male Mecp2-mutant mice [8–13]. All these studies suggested that
MECP2mutation could be involved in cellular mechanisms regulat-
ing short term dynamics of dendritic arborization early in develop-
ment within the frame of maximum neural plasticity. However, the
underlying cause of the dendritic arborization impairment is lar-
gely unknown. Although actin and its regulatory proteins play a
central role in morphogenesis of dendritic spines, recent studiesimary culture from a CDKL5 mutation patient (p.Arg59X mutation). After 8 min
ence in the rate of PMT as compared to the wild-type (WT) culture, suggesting that
Fig. 8. (A) Western blot analysis of total a-tubulin, tyrosinated tubulin and
acetylated tubulin in wild-type (WT) and ﬁbroblasts from patients with RTT
syndrome (p.Arg270X; p.Arg306Cys; p.Arg255X) before and after 8 min depoly-
merization at +4 C. A marked decrease of acetylated tubulin is observed during the
depolymerization kinetics without any changes in total a-tubulin or tyrosinated
tubulin. (B) Quantiﬁcation of the decrease of acetylated tubulin during depolymer-
ization. During depolymerization, tubulins from MeCP2 mutated ﬁbroblasts are
markedly deacetylated as compared to the WT culture, which is deacetylated to a
lesser extent.
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maintenance of mature dendritic spine morphology [27]. Because
we and others identiﬁed dysregulated expression of proteins in-
volved in regulation of MT dynamics and functions (STMN2 and
the ubiquitin-editing enzyme UCHL1, Dynamin I, Dynein I)
[14,15,19], we previously analysed MT dynamics in brain using
two different RTT mouse models and showed an alteration of MT
dynamics in RTT astrocytes [16].
In this report, we showed that human ﬁbroblasts from patients
with RTT syndrome exhibit increased sensitivity to cold-induced
stress as compared to WT controls, suggesting that MECP2 muta-
tion is associated with reduced MT stability. The same results are
obtained with ﬁbroblasts carrying different types of mutations,suggesting that MT dynamics impairment is not dependent on
the mutation type. Because MECP2 is located on the X chromo-
some, primary ﬁbroblast cultures from female patients with RTT
syndrome result in a mosaic for loss of MeCP2 function consisting
of cells that express the wild type MECP2 from the active X and
cells that express the mutant MECP2 from the active X. To elimi-
nate possible changes resulting from inter-individual genetic dif-
ferences, we compared MT stability in clonal cells originating
from the same RTT patient, and we also observed that clonal cul-
ture expressing exclusively the MECP2 mutant allele displayed a
more pronounced response to cold-induced stress than clonal cul-
ture expressing exclusively the WT allele, thus conﬁrming that
MeCP2 deﬁciency may lead to reduced MT stability.
Using a speciﬁc antibody directed against the C-terminal part of
the protein, we compared MT stability in RTT cells expressing the
wild-type allele (MeCP2+) and RTT cells expressing the mutant al-
lele (non-sense mutation) (MeCP2), and interestingly, although
MeCP2  cells are more affected than MeCP2 + cells, all cells from
a RTT patient presented MT stability abnormalities, suggesting that
wild-type cells are likely to be affected in a non-cell-autonomous
fashion by the mutant cells. This notion is in accordance with the
fact that, in heterozygous human patients, the majority of pyrami-
dal cortical neurons show aberrant dendritic morphology [8]. Con-
sidering the similar phenotypes caused by mutations inMECP2 and
CDKL5, an X-linked gene involved in atypical form of RTT, it has
been suggested that the two genes could play a role in a common
pathogenic process [23,24]. Interestingly, it has been shown that
the two proteins are widely co-expressed in the brain and are sim-
ilarly activated during neuronal maturation and synaptogenesis
[28,29]. At the molecular level, the two proteins interact together
and CDKL5 mediates MeCP2 phosphorylation at least in vitro
[23,24]. There are also reasons to believe that MeCP2 also performs
CDKL5-independent functions. When we performed the cold-in-
duced repolymerization experiments on human ﬁbroblasts carry-
ing mutations in the CDKL5 gene, we did not observe any
changes in MT stability. We conclude that MeCP2 status, but not
CDKL5, is associated with microtubule stability.
One explanation of the MT dynamics impairment in MeCP2-
deﬁcient cells may be linked to abnormal post-transcriptional
modiﬁcations of tubulins. We investigated this using speciﬁc anti-
bodies directed against acetylated and tyrosinated tubulins, and
observed a faster deacetylation in the MT from patients with RTT
syndrome as compared to WT. Supporting this notion is the ﬁnding
that, inhibition of the N-acetyltransferase complex (consisting of
N-acetytransferase 1 (NAT1) and arrest defective 1 (ARD1)), which
mediates tubulin acetylation results in less dendritic branches in
cultured Purkinje neurons [30]. However, our results contrast with
a previous study which reported reduced levels of Tyr-a-tubulin
and Glu-a-tubulin proteins in cerebral cortex extracts from pa-
tients with RTT syndrome with almost no decrease in D2 a-tubulin
and total a-tubulin associated with reduced expression of TUBA1B,
TUBA3 (renamed TUBA1A) and TUBA4A. The molecular mechanism
that brings about reduced expression of the TUBA3 gene remains
still obscure [31]. This apparent discrepancy may be explained by
the fact that we and other did not observe dysregulated expression
of tubulin genes either in ﬁbroblasts from human RTT patient nor
in human brain [32,33].
Taken together, our results using biochemical and cellular ap-
proaches indicate that MeCP2 deﬁciency is associated with an
alteration of MT dynamics in a cell-dependent way. RTT cells exhi-
bit increased sensitivity to cold-induced stress as compared to
wild-type controls in a non-cell-autonomous fashion. It is likely
that the increased sensitivity to cold-induced stress observed in
our experiments is the consequence of the global chromatin regu-
lator function of MeCP2 suggested by many authors [33]. These
data are consistent with recent ﬁndings suggesting that the selec-
Fig. 9. Effect of Taxol on MT dynamics of MeCP2-deﬁcient cells. Cells were incubated in the absence of drug or with 250 nM taxol for 30 min, and then subjected to
depolymerization 11 min at 4 C. After a 30 min treatment with 250 nM taxol, RTT ﬁbroblasts no longer show difference in terms of rate of depolymerization, i.e. in terms of
cold-stress sensitivity. Taxol corrected the MT depolymerization defect observed on RTT ﬁbroblasts. WT (wild-type).
252 C. Delépine et al. / FEBS Letters 587 (2013) 245–253tive loss of Mecp2 in non-neuronal cells such as astrocytes elicits,
at least in part, an RTT-like phenotype [34]. Identifying MT dynam-
ics abnormalities in human neurons and astrocytes generated from
RTT induced pluripotent cells is an important area of future inves-
tigation. The involvement of microtubule dysfunction in RTT sug-
gests that it may be possible to amend RTT using microtubule
targeting drugs. In this study, we found that taxol, a drug acting
against microtubule depolymerisation through its binding to b-
tubulin, is able to correct microtubule dynamics alterations in
MeCP2-deﬁcient cells. Our data provide the ﬁrst evidence that a
microtubule stabilizer might have a beneﬁcial effect, opening
new possibilities for the development of novel pharmacological ap-
proaches for the treatment of Rett syndrome.
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